Logo image of ALGID.PA

EGIDE (ALGID.PA) Stock Fundamental Analysis

EPA:ALGID - Euronext Paris - Matif - FR0000072373 - Common Stock - Currency: EUR

0.5257  -0.02 (-3.72%)

Fundamental Rating

2

Taking everything into account, ALGID scores 2 out of 10 in our fundamental rating. ALGID was compared to 48 industry peers in the Electronic Equipment, Instruments & Components industry. ALGID has a bad profitability rating. Also its financial health evaluation is rather negative. ALGID does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALGID had negative earnings in the past year.
In the past year ALGID had a positive cash flow from operations.
ALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFALGID.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 2M -2M -4M

1.2 Ratios

The Return On Assets of ALGID (-14.15%) is worse than 81.25% of its industry peers.
The Return On Equity of ALGID (-65.00%) is worse than 83.33% of its industry peers.
Industry RankSector Rank
ROA -14.15%
ROE -65%
ROIC N/A
ROA(3y)-10.17%
ROA(5y)N/A
ROE(3y)-43.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGID.PA Yearly ROA, ROE, ROICALGID.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -20 -40 -60 -80

1.3 Margins

With a decent Gross Margin value of 60.61%, ALGID is doing good in the industry, outperforming 79.17% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGID has remained more or less at the same level.
ALGID does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 60.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5YN/A
ALGID.PA Yearly Profit, Operating, Gross MarginsALGID.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 20 40 60

More info and screens

1

2. Health

2.1 Basic Checks

ALGID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALGID has more shares outstanding
The debt/assets ratio for ALGID has been reduced compared to a year ago.
ALGID.PA Yearly Shares OutstandingALGID.PA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M
ALGID.PA Yearly Total Debt VS Total AssetsALGID.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of 1.16, we must say that ALGID is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 1.16, ALGID is not doing good in the industry: 85.42% of the companies in the same industry are doing better.
The Debt to FCF ratio of ALGID is 604.53, which is on the high side as it means it would take ALGID, 604.53 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of ALGID (604.53) is worse than 66.67% of its industry peers.
A Debt/Equity ratio of 1.01 is on the high side and indicates that ALGID has dependencies on debt financing.
ALGID's Debt to Equity ratio of 1.01 is on the low side compared to the rest of the industry. ALGID is outperformed by 79.17% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 604.53
Altman-Z 1.16
ROIC/WACCN/A
WACC6.88%
ALGID.PA Yearly LT Debt VS Equity VS FCFALGID.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 5M -5M 10M

2.3 Liquidity

ALGID has a Current Ratio of 1.31. This is a normal value and indicates that ALGID is financially healthy and should not expect problems in meeting its short term obligations.
ALGID's Current ratio of 1.31 is on the low side compared to the rest of the industry. ALGID is outperformed by 70.83% of its industry peers.
ALGID has a Quick Ratio of 1.31. This is a bad value and indicates that ALGID is not financially healthy enough and could expect problems in meeting its short term obligations.
ALGID has a Quick ratio of 0.75. This is amonst the worse of the industry: ALGID underperforms 81.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.75
ALGID.PA Yearly Current Assets VS Current LiabilitesALGID.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M

More info and screens

3

3. Growth

3.1 Past

ALGID shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 63.33%, which is quite impressive.
Looking at the last year, ALGID shows a decrease in Revenue. The Revenue has decreased by -4.87% in the last year.
The Revenue has been growing slightly by 7.00% on average over the past years.
EPS 1Y (TTM)63.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%-19.57%

3.2 Future

Based on estimates for the next years, ALGID will show a very strong growth in Earnings Per Share. The EPS will grow by 23.68% on average per year.
ALGID is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.40% yearly.
EPS Next Y136.87%
EPS Next 2Y48.85%
EPS Next 3Y23.68%
EPS Next 5YN/A
Revenue Next Year4.58%
Revenue Next 2Y13.17%
Revenue Next 3Y0.4%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALGID.PA Yearly Revenue VS EstimatesALGID.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
ALGID.PA Yearly EPS VS EstimatesALGID.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2022 2024 2025 2026 0 -0.1 -0.2 -0.3

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

ALGID reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 12.70 indicates a correct valuation of ALGID.
Based on the Price/Forward Earnings ratio, ALGID is valued a bit cheaper than 75.00% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, ALGID is valued a bit cheaper.
Industry RankSector Rank
PE N/A
Fwd PE 12.7
ALGID.PA Price Earnings VS Forward Price EarningsALGID.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, ALGID is valued a bit more expensive than the industry average as 66.67% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 542.3
EV/EBITDA N/A
ALGID.PA Per share dataALGID.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ALGID's earnings are expected to grow with 23.68% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y48.85%
EPS Next 3Y23.68%

More info and screens

0

5. Dividend

5.1 Amount

ALGID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EGIDE

EPA:ALGID (5/9/2025, 7:00:00 PM)

0.5257

-0.02 (-3.72%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)04-29 2025-04-29
Earnings (Next)10-20 2025-10-20
Inst Owners11.72%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap10.30M
Analysts86.67
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 12.7
P/S 0.31
P/FCF 542.3
P/OCF 43.48
P/B 1.84
P/tB 1.84
EV/EBITDA N/A
EPS(TTM)-0.22
EYN/A
EPS(NY)0.04
Fwd EY7.88%
FCF(TTM)0
FCFY0.18%
OCF(TTM)0.01
OCFY2.3%
SpS1.68
BVpS0.29
TBVpS0.29
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -14.15%
ROE -65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 60.61%
FCFM 0.06%
ROA(3y)-10.17%
ROA(5y)N/A
ROE(3y)-43.03%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.14%
GM growth 5YN/A
F-Score6
Asset Turnover1.28
Health
Industry RankSector Rank
Debt/Equity 1.01
Debt/FCF 604.53
Debt/EBITDA N/A
Cap/Depr 13.73%
Cap/Sales 0.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.75
Altman-Z 1.16
F-Score6
WACC6.88%
ROIC/WACCN/A
Cap/Depr(3y)327.32%
Cap/Depr(5y)N/A
Cap/Sales(3y)3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)63.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-8%
EPS Next Y136.87%
EPS Next 2Y48.85%
EPS Next 3Y23.68%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.87%
Revenue growth 3Y7%
Revenue growth 5YN/A
Sales Q2Q%-19.57%
Revenue Next Year4.58%
Revenue Next 2Y13.17%
Revenue Next 3Y0.4%
Revenue Next 5YN/A
EBIT growth 1Y-543.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-99.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-94.56%
OCF growth 3Y-21.26%
OCF growth 5YN/A